Literature DB >> 26050637

Gray and white matter alterations in hereditary spastic paraplegia type SPG4 and clinical correlations.

Tobias Lindig1, Benjamin Bender, Till-Karsten Hauser, Sarah Mang, Daniel Schweikardt, Uwe Klose, Kathrin N Karle, Rebecca Schüle, Ludger Schöls, Tim W Rattay.   

Abstract

Hereditary spastic paraplegias (HSP) are a group of clinically and genetically heterogeneous disorders with the hallmark of progressive spastic gait disturbance. We used advanced neuroimaging to identify brain regions involved in SPG4, the most common HSP genotype. Additionally, we analyzed correlations between imaging and clinical findings. We performed 3T MRI scans including isotropic high-resolution 3D T1, T2-FLAIR, and DTI sequences in 15 adult patients with genetically confirmed SPG4 and 15 age- and sex-matched healthy controls. Brain volume loss of gray and white matter was evaluated through voxel-based morphometry (VBM) for supra- and infratentorial regions separately. DTI maps of axial diffusivity (AD), radial diffusivity (RD), mean diffusivity (MD), fractional anisotropy (FA), and measured anisotropy (MA1) were analyzed through tract-based special statistics (TBSS). VBM and TBSS revealed a widespread affection of gray and white matter in SPG4 including the corpus callosum, medio-dorsal thalamus, parieto-occipital regions, upper brainstem, cerebellum, and corticospinal tract. Significant correlations with correlation coefficients r > 0.6 between clinical data and DTI findings could be demonstrated for disease duration and disease severity as assessed by the spastic paraplegia rating scale for the pontine crossing tract (AD) and the corpus callosum (RD and FA). Imaging also provided evidence that SPG4 underlies a primarily axonal rather than demyelinating damage in accordance with post-mortem data. DTI is an attractive tool to assess subclinical affection in SPG4. The correlation of imaging findings with disease duration and severity suggests AD, RD, and FA as potential progression markers in interventional studies.

Entities:  

Mesh:

Year:  2015        PMID: 26050637     DOI: 10.1007/s00415-015-7791-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  49 in total

Review 1.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

2.  The Spastic Paraplegia Rating Scale (SPRS): a reliable and valid measure of disease severity.

Authors:  R Schüle; T Holland-Letz; S Klimpe; J Kassubek; T Klopstock; V Mall; S Otto; B Winner; L Schöls
Journal:  Neurology       Date:  2006-08-08       Impact factor: 9.910

3.  Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia.

Authors:  J Hazan; N Fonknechten; D Mavel; C Paternotte; D Samson; F Artiguenave; C S Davoine; C Cruaud; A Dürr; P Wincker; P Brottier; L Cattolico; V Barbe; J M Burgunder; J F Prud'homme; A Brice; B Fontaine; B Heilig; J Weissenbach
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

4.  Classification of the hereditary ataxias and paraplegias.

Authors:  A E Harding
Journal:  Lancet       Date:  1983-05-21       Impact factor: 79.321

5.  Clinical and pathologic findings in hereditary spastic paraparesis with spastin mutation.

Authors:  K D White; P G Ince; M Lusher; J Lindsey; M Cookson; R Bashir; P J Shaw; K M Bushby
Journal:  Neurology       Date:  2000-07-12       Impact factor: 9.910

6.  Specific pattern of early white-matter changes in pure hereditary spastic paraplegia.

Authors:  Thomas Duning; Tobias Warnecke; Anja Schirmacher; Hagen Schiffbauer; Hubertus Lohmann; Siawoosh Mohammadi; Peter Young; Michael Deppe
Journal:  Mov Disord       Date:  2010-09-15       Impact factor: 10.338

7.  The cellular and molecular pathology of the motor system in hereditary spastic paraparesis due to mutation of the spastin gene.

Authors:  Stephen B Wharton; Christopher J McDermott; Andrew J Grierson; Jonathan D Wood; Catherine Gelsthorpe; Paul G Ince; Pamela J Shaw
Journal:  J Neuropathol Exp Neurol       Date:  2003-11       Impact factor: 3.685

8.  Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum.

Authors:  Giovanni Stevanin; Filippo M Santorelli; Hamid Azzedine; Paula Coutinho; Jacques Chomilier; Paola S Denora; Elodie Martin; Anne-Marie Ouvrard-Hernandez; Alessandra Tessa; Naïma Bouslam; Alexander Lossos; Perrine Charles; José L Loureiro; Nizar Elleuch; Christian Confavreux; Vítor T Cruz; Merle Ruberg; Eric Leguern; Djamel Grid; Meriem Tazir; Bertrand Fontaine; Alessandro Filla; Enrico Bertini; Alexandra Durr; Alexis Brice
Journal:  Nat Genet       Date:  2007-02-18       Impact factor: 38.330

9.  Multimodal MRI-based study in patients with SPG4 mutations.

Authors:  Thiago J R Rezende; Milena de Albuquerque; Gustavo M Lamas; Alberto R M Martinez; Brunno M Campos; Raphael F Casseb; Cynthia B Silva; Lucas M T Branco; Anelyssa D'Abreu; Iscia Lopes-Cendes; Fernando Cendes; Marcondes C França
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

10.  Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance.

Authors:  Gerald Pfeffer; Gráinne S Gorman; Helen Griffin; Marzena Kurzawa-Akanbi; Emma L Blakely; Ian Wilson; Kamil Sitarz; David Moore; Julie L Murphy; Charlotte L Alston; Angela Pyle; Jon Coxhead; Brendan Payne; George H Gorrie; Cheryl Longman; Marios Hadjivassiliou; John McConville; David Dick; Ibrahim Imam; David Hilton; Fiona Norwood; Mark R Baker; Stephan R Jaiser; Patrick Yu-Wai-Man; Michael Farrell; Allan McCarthy; Timothy Lynch; Robert McFarland; Andrew M Schaefer; Douglass M Turnbull; Rita Horvath; Robert W Taylor; Patrick F Chinnery
Journal:  Brain       Date:  2014-04-10       Impact factor: 13.501

View more
  13 in total

1.  FAHN/SPG35: a narrow phenotypic spectrum across disease classifications.

Authors:  Tim W Rattay; Tobias Lindig; Jonathan Baets; Katrien Smets; Tine Deconinck; Anne S Söhn; Konstanze Hörtnagel; Kathrin N Eckstein; Sarah Wiethoff; Jennifer Reichbauer; Marion Döbler-Neumann; Ingeborg Krägeloh-Mann; Michaela Auer-Grumbach; Barbara Plecko; Alexander Münchau; Bernd Wilken; Marc Janauschek; Anne-Katrin Giese; Jan L De Bleecker; Els Ortibus; Martine Debyser; Adolfo Lopez de Munain; Aurora Pujol; Maria Teresa Bassi; Maria Grazia D'Angelo; Peter De Jonghe; Stephan Züchner; Peter Bauer; Ludger Schöls; Rebecca Schüle
Journal:  Brain       Date:  2019-06-01       Impact factor: 13.501

2.  Thalamic atrophy in patients with pure hereditary spastic paraplegia type 4.

Authors:  Francisco Grandas; Manuel Desco; Francisco J Navas-Sánchez; Alberto Fernández-Pena; Daniel Martín de Blas; Yasser Alemán-Gómez; Luís Marcos-Vidal; Juan A Guzmán-de-Villoria; Pilar Fernández-García; Julia Romero; Irene Catalina; Laura Lillo; José L Muñoz-Blanco; Andrés Ordoñez-Ugalde; Beatriz Quintáns; Julio Pardo; María-Jesús Sobrido; Susanna Carmona
Journal:  J Neurol       Date:  2021-01-28       Impact factor: 4.849

3.  White Matter Alterations in Spastic Paraplegia Type 5: A Multiparametric Structural MRI Study and Correlations with Biochemical Measurements.

Authors:  Y Liu; Z Ye; J Hu; Z Xiao; F Zhang; X Yang; W Chen; Y Fu; D Cao
Journal:  AJNR Am J Neuroradiol       Date:  2021-11-18       Impact factor: 3.825

4.  Iron-sensitive MR imaging of the primary motor cortex to differentiate hereditary spastic paraplegia from other motor neuron diseases.

Authors:  Mirco Cosottini; Graziella Donatelli; Ivana Ricca; Francesca Bianchi; Daniela Frosini; Vincenzo Montano; Gianmichele Migaleddu; Eleonora Del Prete; Alessandra Tessa; Paolo Cecchi; Claudio D'Amelio; Gabriele Siciliano; Michelangelo Mancuso; Filippo Maria Santorelli
Journal:  Eur Radiol       Date:  2022-05-20       Impact factor: 7.034

Review 5.  Cerebellar pathology in motor neuron disease: neuroplasticity and neurodegeneration.

Authors:  Rangariroyashe H Chipika; Grainne Mulkerrin; Pierre-François Pradat; Aizuri Murad; Fabrice Ango; Cédric Raoul; Peter Bede
Journal:  Neural Regen Res       Date:  2022-11       Impact factor: 6.058

Review 6.  Patient-Derived Stem Cell Models in SPAST HSP: Disease Modelling and Drug Discovery.

Authors:  Gautam Wali; Carolyn M Sue; Alan Mackay-Sim
Journal:  Brain Sci       Date:  2018-07-31

Review 7.  Neuroimaging in Hereditary Spastic Paraplegias: Current Use and Future Perspectives.

Authors:  Felipe Franco da Graça; Thiago Junqueira Ribeiro de Rezende; Luiz Felipe Rocha Vasconcellos; José Luiz Pedroso; Orlando Graziani P Barsottini; Marcondes C França
Journal:  Front Neurol       Date:  2019-01-16       Impact factor: 4.003

8.  Ascending Axonal Degeneration of the Corticospinal Tract in Pure Hereditary Spastic Paraplegia: A Cross-Sectional DTI Study.

Authors:  Julia List; Zacharias Kohl; Juergen Winkler; Franz Marxreiter; Arnd Doerfler; Manuel A Schmidt
Journal:  Brain Sci       Date:  2019-10-09

9.  Clinical and Paraclinical Indicators of Motor System Impairment in Hereditary Spastic Paraplegia: A Pilot Study.

Authors:  Andrea Martinuzzi; Domenico Montanaro; Marinela Vavla; Gabriella Paparella; Paolo Bonanni; Olimpia Musumeci; Erika Brighina; Hana Hlavata; Giuseppe Rossi; Gayane Aghakhanyan; Nicola Martino; Alessandra Baratto; Maria Grazia D'Angelo; Francesca Peruch; Marianna Fantin; Alessia Arnoldi; Andrea Citterio; Chiara Vantaggiato; Vincenzo Rizzo; Antonio Toscano; Nereo Bresolin; Maria Teresa Bassi
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

10.  Cortical Damage Associated With Cognitive and Motor Impairment in Hereditary Spastic Paraplegia: Evidence of a Novel SPAST Mutation.

Authors:  Jian-Zhong Lin; Hong-Hua Zheng; Qi-Lin Ma; Chen Wang; Li-Ping Fan; Han-Ming Wu; Dan-Ni Wang; Jia-Xing Zhang; Yi-Hong Zhan
Journal:  Front Neurol       Date:  2020-05-27       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.